Shana O. Kelley

Shana O. Kelley is a scientist and Distinguished Professor at the University of Toronto's Faculty of Pharmacy and Faculty of Medicine. Her research includes the development of new technologies for clinical diagnostics and drug delivery.[1]

Career

Kelley received her B.S. from Seton Hall University in 1994 and her Ph.D. in chemistry from the California Institute of Technology in 1999. Her dissertation was entitled "Electron Transfer through the DNA Double Helix: Spectroscopic and Electrochemical Studies".[2]

Kelley was named among the Top 100 Innovators by MIT's Technology Review while she was a professor at Boston College.[3]

She is a founder of two molecular diagnostics companies Xagenic Inc. and GeneOhm Sciences.[4] GeneOhm was acquired by Becton Dickinson in early 2006.[5]

References
  1. "Shana O. Kelley". University of Toronto.
  2. O., Kelley, Shana (1999). "Electron transfer through the DNA double helix: spectroscopic and electrochemical studies". thesis.library.caltech.edu. Retrieved 2018-11-14.
  3. Review, MIT Technology. "Innovator Under 35: Shana Kelley, 34". MIT Technology Review. Retrieved 2018-11-14.
  4. "Shana Kelley: A quicker way to diagnose disease". Retrieved 2018-11-14.
  5. "BD Acquires GeneOhm Sciences for $230M in Bid to Bolster Infectious-Disease Play". GenomeWeb. Retrieved 2018-11-14.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.